MedTrace Logo

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement

NCT03937687 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2021-09-30

No results posted yet for this study

Summary

The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic variables in response to this combination.

Conditions

  • Caffeine, Teacrine, and Dynamine: Effects on Performance

Interventions

DRUG

Caffeine+TeaCrine+Dynamine

combination of caffeine, TeaCrine, and Dynamine

DRUG

Placebo

Placebo

DRUG

Caffeine

Caffeine

Sponsors & Collaborators

  • Compound Solutions Inc.

    collaborator INDUSTRY

  • Rutgers, The State University of New Jersey

    collaborator OTHER

  • University of South Carolina

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
63 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-04
Primary Completion
2020-11-15
Completion
2020-11-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03937687 on ClinicalTrials.gov